Impact Biomedical (IBO) Enterprise Value (2022 - 2026)
Impact Biomedical (IBO) posted Enterprise Value of $3.2 million for Q1 2026, little changed on a QoQ basis from $3.2 million in Q4 2025, and up 95.69% year-over-year from $1.6 million in Q1 2025.
Impact Biomedical (IBO) Enterprise Value (2022 - 2026) Analysis & Trends
Impact Biomedical's Enterprise Value history runs 5 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- Quarterly Enterprise Value rose 95.69% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 95.69% YoY) and the FY2025 annual result came in at $3.2 million, up 231.05% from the prior year.
- Enterprise Value was $3.2 million for Q1 2026 at Impact Biomedical, roughly flat from $3.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at $3.2 million in Q4 2025 and bottomed at $979000.0 in Q4 2024.
- A 5-year average of $2.8 million and a median of $3.0 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 67.79% — and 2025, when it surged 231.05%.
- Impact Biomedical's Enterprise Value stood at $3.1 million in 2022, then decreased by 2.25% to $3.0 million in 2023, then slumped by 67.79% to $979000.0 in 2024, then jumped by 231.05% to $3.2 million in 2025, then fell by 0.43% to $3.2 million in 2026.
- Business Quant data shows IBO's Enterprise Value at $3.2 million in Q1 2026, $3.2 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 3.24 Mn |
| Sep 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.96 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 979,000.00 |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.01 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 3.04 Mn |
| Sep 30, 2023 | 3.07 Mn |
| Jun 30, 2023 | 3.08 Mn |
| Dec 31, 2022 | 3.11 Mn |